Article
Preliminary Evidence for Sex Differences in CYP2C19 Metabolic Capacity During Psychotropic Drug Treatment.
Genes - 21 Jun 2026
Eiberger Janina, Weber Heike, Reif Andreas, Deckert Jürgen, Walther Sebastian, Hahn Martina, Scherf-Clavel Maike
Abstract excerpt
Background/Objectives: Sex-specific differences in the pharmacokinetics of psychotropic drugs are gaining increasing clinical relevance, but only limited data are currently available on sex-specific effects within genetically defined metabolizer phenotype categories. The objective of this study was to assess genotype-dependent sex differences in the metabolic capacity of the drug-metabolizing enzymes CYP2D6 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
